Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
GnRH signaling pathway | R-HSA-168638 | map04912 | pralidoxime | 135398747 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | pralidoxime | 135398747 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | pralidoxime | 135398747 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pralidoxime | 135398747 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | pralidoxime | 135398747 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | pralidoxime | 135398747 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | paracetamol | 1983 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | paracetamol | 1983 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | paracetamol | 1983 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | paracetamol | 1983 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | paracetamol | 1983 | drug-path |
Asthma | R-HSA-444620 | map05310 | paracetamol | 1983 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | paracetamol | 1983 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | paracetamol | 1983 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | paracetamol | 1983 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | paracetamol | 1983 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | paracetamol | 1983 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | paracetamol | 1983 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | paracetamol | 1983 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | paracetamol | 1983 | drug-path |